Yervoy

0:11:42

ASCO Lung Cancer Roundtable - NSCLC Trial Updates: Checkmate 227 Opdivo Yervoy Combination Today

0:01:15

Dr. Postow on Nivolumab Combined With Ipilimumab in Melanoma

0:02:35

Dr. Atkins on Long-Term Survival Benefit of Nivolumab/Ipilimumab in Advanced Melanoma

0:04:50

Ipilimumab/Nivolumab in First-Line mRCC

0:01:00

2 Drugs Making Strides in Oncology: Yervoy & Lenvima #Monthlylapinhealth Newsletter reel

0:02:08

Nivolumab with ipilimumab for mRCC

0:00:43

Dr. Eng on the FDA Approval of Nivolumab Plus Ipilimumab in CRC

0:00:39

Dr. Atkinson on When to Use Nivolumab Monotherapy Versus Nivolumab/Ipilimumab Combination

0:03:47

Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer

0:02:00

Dr. Overman on Nivolumab and Ipilimumab in Patients With MSI-H CRC

0:01:22

Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma

0:06:01

Metastatic RCC: Using Frontline Ipilimumab/Nivolumab

0:03:16

Optimizing the Use of Ipilimumab/Nivolumab in mRCC

0:01:27

Dr. Chiang Discusses Ipilimumab Plus Nivolumab in Small Cell Lung Cancer

0:06:12

Nivolumab vs ipilimumab for high risk melanoma patients

0:02:01

Dr. Reardon on Nivolumab/Ipilimumab in Glioblastoma

0:04:59

Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with res...

0:01:25

Dr. Ott Discusses Ipilimumab and Nivolumab in Melanoma

0:01:26

Dr. Andre on Nivolumab Plus Ipilimumab in dMMR/MSI-H mCRC

0:01:00

PRIME-HCC: ipilimumab and nivolumab in liver cancer

0:01:53

İpilimumab İmmunoterapi Prof Dr Başak Oyan Uluç

0:01:49

COSMIC-313: cabozantinib with nivolumab and ipilimumab in untreated aRCC

0:01:16

Opdivo + Yervoy Commercial (2024-2025)

0:02:48

CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma